Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    0(0%)

    Phase Distribution

    Phase 2/3
    1
    50%
    Phase 3
    1
    50%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    1

    Late Stage

    Phase Distribution2 total trials
    Phase 2/3Combined phases
    1(50.0%)
    Phase 3Large-scale testing
    1(50.0%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 1 finished

    Non-Completion Rate

    100.0%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Terminated(1)

    Detailed Status

    Not yet recruiting1
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    N/A
    Most Advanced
    Phase 2/3

    Trials by Phase

    Phase 2/31 (50.0%)
    Phase 31 (50.0%)

    Trials by Status

    not_yet_recruiting150%
    withdrawn150%

    Recent Activity

    0 active trials
    Showing 2 of 2
    not_yet_recruitingphase_3

    COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHLOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE

    NCT07652801
    withdrawnphase_2_3

    Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial

    NCT00293735

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT07652801Phase 3

    COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHLOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE

    Not Yet Recruiting
    NCT00293735Phase 2/3

    Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial

    Withdrawn

    All 2 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    2